EMA approval · 2022-10-14

First therapy to treat transplant patients with post-transplant lymphoproliferative disease

EMA announces the first therapy approved to treat post-transplant lymphoproliferative disease in transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.